Pharmaceutical company
Appears in 1 story
Incumbent in same indication; faces new competition
For 25 years, drug companies have tried to design medicines that don't just block harmful proteins but destroy them outright. On May 1, the U.S. Food and Drug Administration (FDA) approved the first one. VEPPANU, developed by biotech Arvinas and Pfizer, treats a hard-to-treat form of metastatic breast cancer by hijacking the cell's own garbage-disposal system to shred a mutated estrogen receptor that fuels the tumor.
Updated Yesterday
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
